Engineered Human Dendritic Cell Exosomes as Effective Delivery System for Immune Modulation
International Journal of Molecular Sciences · 11.07.2023 · 24 (14) · 11306
DOI: 10.3390/ijms241411306 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.07.2023. Verfasst von Ranya Elsayed und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontics, Dental College of Georgia, Augusta University, Augusta, GA 30912, USA. Hauptthemen laut MEDLINE: Exosomes. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NIH/NIDCR.
Abstract (Originalsprache)
Exosomes (exos) contain molecular cargo of therapeutic and diagnostic value for cancers and other inflammatory diseases, but their therapeutic potential for periodontitis (PD) remains unclear. Dendritic cells (DCs) are the directors of immune response and have been extensively used in immune therapy. We previously reported in a mouse model of PD that custom murine DC-derived exo subtypes could reprogram the immune response toward a bone-sparing or bone-loss phenotype, depending on immune profile. Further advancement of this technology requires the testing of human DC-based exos with human target cells. Our main objective in this study is to test the hypothesis that human monocyte-derived dendritic cell (MoDC)-derived exos constitute a well-tolerated and effective immune therapeutic approach to modulate human target DC and T cell immune responses in vitro. MoDC subtypes were generated with TGFb/IL-10 (regulatory (reg) MoDCs, CD86lowHLA-DRlowPDL1high), E. coli LPS (stimulatory (stim) MoDCs, CD86highHLA-DRhighPDL1low) and buffer (immature (i) MoDCs, CD86lowHLA-DRmedPDL1low). Exosomes were isolated from different MoDC subtypes and characterized. Once released from the secreting cell into the surrounding environment, exosomes protect their prepackaged molecular cargo and deliver it to bystander cells. This modulates the functions of these cells, depending on the cargo content. RegMoDCexos were internalized by recipient MoDCs and induced upregulation of PDL1 and downregulation of costimulatory molecules CD86, HLADR, and CD80, while stimMoDCexos had the opposite influence. RegMoDCexos induced CD25+Foxp3+ Tregs, which expressed CTLA4 and PD1 but not IL-17A. In contrast, T cells treated with stimMoDCexos induced IL-17A+ Th17 T cells, which were negative for immunoregulatory CTLA4 and PD1. T cells and DCs treated with iMoDCexos were immune ‘neutral’, equivalent to controls. In conclusion, human DC exos present an effective delivery system to modulate human DC and T cell immune responses in vitro. Thus, MoDC exos may present a viable immunotherapeutic agent for modulating immune response in the gingival tissue to inhibit bone loss in periodontal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontics, Dental College of Georgia, Augusta University, Augusta, GA 30912, USA.
- Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
ORCID-Profile: Yutao Liu
Förderung
- NIDCR NIH HHS
- NIH/NIDCR
Zitieren
APA
Elsayed, R., Elashiry, M., Tran, C., Yang, T., Carroll, A., Liu, Y., Hamrick, M., & Cutler, C. W. (2023). Engineered Human Dendritic Cell Exosomes as Effective Delivery System for Immune Modulation. International Journal of Molecular Sciences, 24(14), 11306. https://doi.org/10.3390/ijms241411306
Vancouver
Elsayed R, Elashiry M, Tran C, Yang T, Carroll A, Liu Y, et al. Engineered Human Dendritic Cell Exosomes as Effective Delivery System for Immune Modulation. International Journal of Molecular Sciences. 2023;24(14):11306. doi:10.3390/ijms241411306
BibTeX
@article{Elsayed2023,
author = {Elsayed, Ranya and Elashiry, Mahmoud and Tran, Cathy and Yang, Tigerwin and Carroll, Angelica and Liu, Yutao and Hamrick, Mark and Cutler, Christopher W},
title = {Engineered Human Dendritic Cell Exosomes as Effective Delivery System for Immune Modulation},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {14},
pages = {11306},
doi = {10.3390/ijms241411306}
}
EUVIMED